Advanced search
Publication Cover
Future Science OA Volume 10, 2024 - Issue 1
Submit an article Journal homepage
362
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

A chemical approach facilitates CRISPRa-only human iPSC generation and minimizes the number of targeted loci required

Ramzey Abujarour1 Fate Therapeutics, San Diego, CA 92121, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7849-9441
ORCID Icon,
Jason Dinella1 Fate Therapeutics, San Diego, CA 92121, USA
,
Mochtar Pribadi1 Fate Therapeutics, San Diego, CA 92121, USA
,
Lauren K Fong1 Fate Therapeutics, San Diego, CA 92121, USA
,
Matthew Denholtz1 Fate Therapeutics, San Diego, CA 92121, USA
,
Alma Gutierrez1 Fate Therapeutics, San Diego, CA 92121, USA
,
Matt Haynes1 Fate Therapeutics, San Diego, CA 92121, USA
,
Enaaya Mahmood1 Fate Therapeutics, San Diego, CA 92121, USA
,
Tom T Lee1 Fate Therapeutics, San Diego, CA 92121, USA
,
Sheng Ding2 School of Pharmaceutical Sciences, Tsinghua University, Beijing, China
&
Bahram Valamehr1 Fate Therapeutics, San Diego, CA 92121, USA
 show all
Article: FSO964 | Received 27 Oct 2023, Accepted 19 Jan 2024, Published online: 06 Feb 2024

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.